[go: up one dir, main page]

Mayo et al., 2003 - Google Patents

Extrahepatic manifestations of hepatitis C infection

Mayo et al., 2003

View PDF
Document ID
6833233508179612850
Author
Mayo M
Kaplan N
Palmer B
Publication year
Publication venue
The American journal of the medical sciences

External Links

Snippet

Hepatitis C virus (HCV) affects 1.8% of the American population, and approximately 38% of patients with HCV will manifest symptoms of at least 1 extrahepatic manifestation during the illness. Renal disease, neuropathy, lymphoma, and Sjögren syndrome with or without mixed …
Continue reading at www.amjmedsci.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Similar Documents

Publication Publication Date Title
Mayo et al. Extrahepatic manifestations of hepatitis C infection
Tedeschi et al. Cryoglobulinemia
Saadoun et al. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation
Ratziu et al. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease
Ferri Mixed cryoglobulinemia
Hadziyannis The spectrum of extrahepatic manifestations in hepatitis C virus infection
Ferri et al. Cryoglobulinemic vasculitis
McFarlane et al. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?
Roth et al. De novo membranoproliferative glomerulonephritis in hepatitis C virus–infected renal allograft recipients
Lunel et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage
Takase et al. The alcohol‐altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease
Ali et al. Hepatitis C infection: a systemic disease with extrahepatic manifestations
Pechère-Bertschi et al. Hepatitis C: a possible etiology for cryoglobulinaemia type II
Morra Cryoglobulinemia
Zachou et al. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases
McTaggart et al. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation
Kubo et al. High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus
Frazer et al. Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH
Agnello Mixed cryoglobulinemia and other extrahepatic manifestations of hepatitis C virus infection
Durazzo et al. Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?
CA2791676A1 (en) Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients
Mayo Beyond the liver: extrahepatic manifestations of chronic hepatitis C infection
Czaja Autoimmune liver disease
Stokes et al. Glomerular diseases associated with nephrotic syndrome and proteinuria
Silva et al. Prevalence of hepatitis C virus markers in Sri Lankan patients with alcoholic cirrhosis